• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 NGS 技术在原发性肿瘤中转录变化区分转移性和非转移性精原细胞瘤。

Discriminating metastasised from non-metastasised seminoma based on transcriptional changes in primary tumours using NGS.

机构信息

1] Department of Urology, Federal Armed Forces Hospital, Hamburg 22049, Germany [2] Bundeswehr Institute of Radiobiology, Munich 80937, Germany.

1] Bundeswehr Institute of Radiobiology, Munich 80937, Germany [2] Department of Urology, Federal Armed Forces Central Hospital, Koblenz 56072, Germany.

出版信息

Br J Cancer. 2014 May 27;110(11):2738-46. doi: 10.1038/bjc.2014.134. Epub 2014 May 1.

DOI:10.1038/bjc.2014.134
PMID:24786602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4037819/
Abstract

BACKGROUND

We aimed to better discriminate (occult) metastasised from non-metastasised seminoma based on transcriptional changes of small RNAs in the primary tumour.

METHODS

Total RNAs including small RNAs were isolated from five testicular tumours of each, lymphogenic, occult and non-metastasised patients. Next-generation sequencing (SOLID, Life Technologies) was used to examine transcriptional changes. Small RNAs showing ⩾50 reads and a significant ⩾2-fold difference using non-metastasised tumours as the reference group were examined in univariate logistic regression analysis and combinations of two small RNAs were further examined using support vector machines.

RESULTS

On average, 1.3 × 10(7), 1.4 × 10(7) and 1.7 × 10(7) small RNA reads were detectable in non-metastasised, occult and lymphogenic metastasised seminoma, respectively, of which 30-32% remained after trimming. Between 59 and 68% represented annotated reads and between 8.6 and 11% were annotated small RNA tags. Of them, 137 small RNAs showed>50 reads and a two-fold difference to the reference. In univariate analysis, 32-38 small RNAs significantly discriminated lymphogenic/occult from non-metastasised seminoma, and among these different comparisons, it were the same small RNAs in 51-88%. Many combinations of two of these small RNAs allowed a complete discrimination of metastasised from non-metastasised seminoma irrespective of the metastasis subtype.

CONCLUSIONS

Metastasised and non-metastasised seminoma can be completely discriminated with a combination of two small RNAs.

摘要

背景

我们旨在通过原发肿瘤中小 RNA 的转录变化更好地区分(隐匿性)转移与非转移的精原细胞瘤。

方法

从每个淋巴转移、隐匿性和非转移的患者的五个睾丸肿瘤中分离总 RNA 包括小 RNA。使用下一代测序(SOLID,Life Technologies)来检查转录变化。使用非转移肿瘤作为参考组,使用单变量逻辑回归分析检查显示 ⩾50 个读数且差异显著 ⩾2 倍的小 RNA,并使用支持向量机进一步检查两个小 RNA 的组合。

结果

平均而言,非转移、隐匿性和淋巴转移的精原细胞瘤分别可检测到 1.3×10(7)、1.4×10(7)和 1.7×10(7)个小 RNA 读数,其中修剪后保留了 30-32%。其中 59-68%代表注释的读数,8.6-11%为注释的小 RNA 标签。其中,有 137 个小 RNA 的读数>50 且与参考值相差两倍。在单变量分析中,32-38 个小 RNA 可显著区分淋巴转移/隐匿性与非转移的精原细胞瘤,在这些不同的比较中,有 51-88%的小 RNA 是相同的。这些小 RNA 中的两个组合可以完全区分转移和非转移的精原细胞瘤,而与转移亚型无关。

结论

转移和非转移的精原细胞瘤可以通过两个小 RNA 的组合完全区分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5c3/4037819/e7a5a44229ac/bjc2014134f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5c3/4037819/e7a5a44229ac/bjc2014134f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5c3/4037819/e7a5a44229ac/bjc2014134f1.jpg

相似文献

1
Discriminating metastasised from non-metastasised seminoma based on transcriptional changes in primary tumours using NGS.基于 NGS 技术在原发性肿瘤中转录变化区分转移性和非转移性精原细胞瘤。
Br J Cancer. 2014 May 27;110(11):2738-46. doi: 10.1038/bjc.2014.134. Epub 2014 May 1.
2
Small RNAs in the peripheral blood discriminate metastasized from non-metastasized seminoma.外周血中的小RNA可区分转移性与非转移性精原细胞瘤。
Mol Cancer. 2014 Mar 6;13:47. doi: 10.1186/1476-4598-13-47.
3
Clinically apparent and occult metastasized seminoma: almost indistinguishable on the transcriptional level.临床明显和隐匿性转移精原细胞瘤:在转录水平上几乎无法区分。
PLoS One. 2014 May 1;9(5):e95009. doi: 10.1371/journal.pone.0095009. eCollection 2014.
4
Predicting metastasized seminoma using gene expression.基于基因表达预测转移性精原细胞瘤。
BJU Int. 2012 Jul;110(2 Pt 2):E14-20. doi: 10.1111/j.1464-410X.2011.10778.x. Epub 2012 Jan 13.
5
The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.精原细胞瘤的转移潜能与特定的 microRNA 模式相关。
Andrology. 2020 Nov;8(6):1687-1698. doi: 10.1111/andr.12838. Epub 2020 Aug 5.
6
Testicular cancer: identifying occult metastatic seminoma using two small RNAs.睾丸癌:利用两种小RNA鉴定隐匿性转移性精原细胞瘤
Nat Rev Urol. 2014 Jun;11(6):306. doi: 10.1038/nrurol.2014.117. Epub 2014 May 27.
7
Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours.用于预测 I 期睾丸生殖细胞肿瘤复发的基因表达特征。
BJU Int. 2018 Nov;122(5):814-822. doi: 10.1111/bju.14372. Epub 2018 May 31.
8
OCT4 staining increases the detection of lymphatic/vascular invasion in pure seminoma of the testis obscured by prominent lymphohistiocytic inflammation.OCT4染色可提高对睾丸纯精原细胞瘤中淋巴管/血管侵犯的检测率,这些侵犯在显著的淋巴组织细胞性炎症掩盖下不易被发现。
Pathology. 2016 Apr;48(3):210-3. doi: 10.1016/j.pathol.2016.02.009. Epub 2016 Mar 8.
9
Regulation network analysis of testicular seminoma at various stages of progression.睾丸精原细胞瘤不同进展阶段的调控网络分析
Genet Mol Res. 2013 Mar 11;12(4):4297-307. doi: 10.4238/2013.March.11.11.
10
Immunohistochemistry expression of P53, Ki67, CD30, and CD117 and presence of clinical metastasis at diagnosis of testicular seminoma.睾丸精原细胞瘤诊断时P53、Ki67、CD30和CD117的免疫组化表达及临床转移情况
Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):147-52. doi: 10.1097/PAI.0b013e3181f05a66.

引用本文的文献

1
Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.I期精原细胞瘤监测中复发风险的预后模型评估。
Cancer Med. 2015 Jan;4(1):155-60. doi: 10.1002/cam4.324. Epub 2014 Sep 19.
2
Testicular cancer: identifying occult metastatic seminoma using two small RNAs.睾丸癌:利用两种小RNA鉴定隐匿性转移性精原细胞瘤
Nat Rev Urol. 2014 Jun;11(6):306. doi: 10.1038/nrurol.2014.117. Epub 2014 May 27.

本文引用的文献

1
Clinically apparent and occult metastasized seminoma: almost indistinguishable on the transcriptional level.临床明显和隐匿性转移精原细胞瘤:在转录水平上几乎无法区分。
PLoS One. 2014 May 1;9(5):e95009. doi: 10.1371/journal.pone.0095009. eCollection 2014.
2
The search for biomarkers of metastatic seminoma.寻找转移性精原细胞瘤的生物标志物。
J Urol. 2013 Sep;190(3):1046-51. doi: 10.1016/j.juro.2013.04.022. Epub 2013 Apr 10.
3
Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing.
睾丸生殖细胞癌的流行病学特征变化:诊断时的年龄和精原细胞瘤的相对频率持续显著增加。
Urol Oncol. 2014 Jan;32(1):33.e1-6. doi: 10.1016/j.urolonc.2012.12.002. Epub 2013 Feb 6.
4
MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.血清 microRNAs miR-371-3 作为睾丸生殖细胞肿瘤管理的诊断工具。
Br J Cancer. 2012 Nov 6;107(10):1754-60. doi: 10.1038/bjc.2012.469. Epub 2012 Oct 11.
5
Predicting metastasized seminoma using gene expression.基于基因表达预测转移性精原细胞瘤。
BJU Int. 2012 Jul;110(2 Pt 2):E14-20. doi: 10.1111/j.1464-410X.2011.10778.x. Epub 2012 Jan 13.
6
[EAU guidelines on testicular cancer: 2011 update. European Association of Urology].[欧洲泌尿外科学会睾丸癌指南:2011年更新版]
Actas Urol Esp. 2012 Mar;36(3):127-45. doi: 10.1016/j.acuro.2011.06.017. Epub 2011 Dec 20.
7
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.基质 PTEN 调控的 miR-320 对肿瘤微环境的重编程。
Nat Cell Biol. 2011 Dec 18;14(2):159-67. doi: 10.1038/ncb2396.
8
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines.顺铂耐药生殖细胞肿瘤细胞系中的微小 RNA 表达。
Mol Cancer. 2011 May 15;10:52. doi: 10.1186/1476-4598-10-52.
9
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.miR-15a 和 miR-16 对前列腺癌中肿瘤与微环境相互作用的调控。
Oncogene. 2011 Oct 13;30(41):4231-42. doi: 10.1038/onc.2011.140. Epub 2011 May 2.
10
Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies.睾丸精原细胞瘤治疗方法的演变:基于人群的选择性应用积极治疗的结果。
Ann Oncol. 2011 Apr;22(4):808-814. doi: 10.1093/annonc/mdq466. Epub 2010 Oct 6.